Sunstone Life Science Ventures is a European, early-stage VC investing in novel pharmaceutical ingredients for human therapeutic use
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 15, 2022
Minervax
|
Series C | €22M | Biotechnology | — |
Dec 15, 2020
Minervax
|
Series B | €47.40M | Biotechnology | — |
Nov 12, 2020
Synendos Therapeutics
|
Series A | Fr20M | Health Care | Yes |
Jan 21, 2019
Minervax
|
Grant | €4.40M | Biotechnology | — |
Feb 15, 2016
Minervax
|
Series Unknown | €2.20M | Biotechnology | — |